Two Private Equity (PE) Firms Invest in US Dental Lab Platform, Covering 16 Labs Across 12 States

Image Source: Apex Dental Laboratory Group

DentalGoodNews | March 31, 2026 – Private Equity (PE) firm LongueVue Capital (hereinafter referred to as "LVC") announced that it has completed a strategic investment in the U.S. dental laboratory platform Apex Dental Laboratory Group (hereinafter referred to as "Apex") in partnership with Private Equity (PE) firm Swaney Group Capital (hereinafter referred to as "SGC"). The specific financial terms of the transaction were not disclosed.

Founded in 2015 and headquartered in Waco, Texas, Apex operates a national network of 16 dental laboratories across 12 states in the U.S., with approximately 400 team members. The company provides 100% U.S.-manufactured, end-to-end restorative solutions, with products covering crowns, bridges, full-arch restorations, dentures, veneers, aligners, surgical guides, and dental implants. Apex owns a portfolio of differentiated brands, including Kinder Krowns® (which launched the first 3D-printed pediatric dental crown in 2024), Snap-On Smile®, Lumineers®, and SurgicalGuides.com.

Ryan Nagim, Managing Partner of LVC, stated that dental laboratories play a crucial role in delivering high-quality care and improving patient outcomes. Apex's commitment to innovation and domestic manufacturing aligns strongly with LVC's strategy of investing in healthcare businesses that deliver clinical value. SGC will collaborate with LVC and management to execute Apex's value creation plan, driving organic growth and strategic acquisitions through operational excellence and technology investments.

Bill Braun, a dental laboratory executive with extensive industry experience, will join as an Operating Partner at LVC and Executive Chairman of Apex. Braun previously served as CEO and President of DDS Lab, one of the largest national dental laboratory platforms in the U.S., and has a strong background in digital workflows and operational transformation. Braun expressed his anticipation to further solidify Apex's position as a leading U.S. dental laboratory platform by enhancing its value proposition and accelerating growth.